ELISA L.
- Country
- Italy
- Department
- SC UCO Ematologia
Research Overview
- Phase II Evaluation of Rituximab and Golcadomide Combination Therapy in Frail Elderly Patients with Diffuse Large B-Cell Non-Hodgkin Lymphoma
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia
- Long-term Safety and Efficacy Evaluation of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia: A Phase 3 Open-label Multicenter Continuation Trial
Data & Insights
Has run more than one trial at 36 of 59 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in treating Diffuse Large B-cell Lymphoma (DLBCL), with particular focus on developing therapeutic approaches for elderly patients. Their research interests center on innovative treatment strategies for non-Hodgkin Lymphoma.
- B-cell lymphoma therapeutics
- Geriatric oncology
- Novel treatment combinations
Their expertise extends to developing chemotherapy-free treatment approaches for vulnerable patient populations.
Geriatric Medicine
The investigator focuses on addressing the specific needs of frail elderly patients with blood cancers. Their work involves evaluating treatment tolerability and effectiveness in older populations.
- Frailty assessment in cancer care
- Age-adapted therapy protocols
- Treatment optimization for elderly
Their research emphasizes tailored therapeutic approaches that consider age-related factors in treatment planning.
Immunotherapy
The investigator specializes in targeted immunotherapy approaches for lymphoma treatment. Their work involves investigating antibody-based therapies and novel therapeutic combinations.
- Antibody therapy
- Targeted treatment approaches
- Alternative treatment strategies
Their research explores non-chemotherapy based treatment options in lymphoma care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.